CVS Health Corporation (CVS): Price and Financial Metrics
CVS Health Corporation (CVS)
Today's Latest Price: $57.65 USD
Updated Sep 29 3:15pm
Add CVS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 4 in Medical - Drug Stores
See all "A" rated Strong Buy stocks
CVS Stock Summary
- With a market capitalization of $75,826,277,893, CVS HEALTH Corp has a greater market value than 97.47% of US stocks.
- CVS's went public 34.77 years ago, making it older than 92.87% of listed US stocks we're tracking.
- The volatility of CVS HEALTH Corp's share price is greater than that of merely 3.72% US stocks with at least 200 days of trading history.
- Stocks that are quantitatively similar to CVS, based on their financial statements, market capitalization, and price volatility, are ANTM, MDLZ, SHW, BKNG, and TGT.
- Visit CVS's SEC page to see the company's official filings. To visit the company's web site, go to www.cvshealth.com.
CVS Stock Price Chart Technical Analysis Charts
CVS Price/Volume Stats
| Current price | $57.65 | 52-week high | $77.03 |
| Prev. close | $57.94 | 52-week low | $52.04 |
| Day low | $57.05 | Volume | 4,320,998 |
| Day high | $57.95 | Avg. volume | 8,842,096 |
| 50-day MA | $61.87 | Dividend yield | 3.45% |
| 200-day MA | $64.60 | Market Cap | 75.45B |
CVS Health Corporation (CVS) Company Bio
CVS Health Corporation provides integrated pharmacy health care services in the United States. The company operates through Pharmacy Services and Retail Pharmacy segments. The company was founded in 1892 and is based in Woonsocket, Rhode Island.
CVS Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $57.65 | $267.85 | 362% |
We started the process of determining a valid price forecast for CVS HEALTH Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that CVS HEALTH Corp ranked in the 74th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 364.5% on a DCF basis. The most interesting components of our discounted cash flow analysis for CVS HEALTH Corp ended up being:
- The company has produced more trailing twelve month cash flow than 96.51% of its sector Healthcare.
- 45% of the company's capital comes from equity, which is greater than just 24.4% of stocks in our cash flow based forecasting set.
- CVS HEALTH Corp's weighted average cost of capital (WACC) is 6%; for context, that number is higher than only 1.3% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 353% |
| 1% | 358% |
| 2% | 362% |
| 3% | 367% |
| 4% | 371% |
| 5% | 376% |
Want more companies with a valuation profile/forecast similar to that of CVS HEALTH Corp? See MYL, ABBV, ANTM, RDNT, and HUM.
Loading social stream, please wait...